CN102186968A - 从脂肪组织获得细胞群的方法 - Google Patents

从脂肪组织获得细胞群的方法 Download PDF

Info

Publication number
CN102186968A
CN102186968A CN200980141395.4A CN200980141395A CN102186968A CN 102186968 A CN102186968 A CN 102186968A CN 200980141395 A CN200980141395 A CN 200980141395A CN 102186968 A CN102186968 A CN 102186968A
Authority
CN
China
Prior art keywords
cells
cell
antibody
certain embodiments
adipose tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200980141395.4A
Other languages
English (en)
Chinese (zh)
Inventor
安东尼·多诺夫里奥
德拉拉·莫特拉赫
大卫·L·阿姆拉尼
埃米·科恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare SA
Baxter International Inc
Original Assignee
Baxter Healthcare SA
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare SA, Baxter International Inc filed Critical Baxter Healthcare SA
Publication of CN102186968A publication Critical patent/CN102186968A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653—Adipocytes; Adipose tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
CN200980141395.4A 2008-10-17 2009-10-19 从脂肪组织获得细胞群的方法 Pending CN102186968A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10635308P 2008-10-17 2008-10-17
US61/106,353 2008-10-17
PCT/US2009/061185 WO2010045645A1 (en) 2008-10-17 2009-10-19 Methods of obtaining cell populations from adipose tissue

Publications (1)

Publication Number Publication Date
CN102186968A true CN102186968A (zh) 2011-09-14

Family

ID=41381576

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200980141395.4A Pending CN102186968A (zh) 2008-10-17 2009-10-19 从脂肪组织获得细胞群的方法

Country Status (7)

Country Link
US (1) US20110274667A1 (https=)
EP (1) EP2356214A1 (https=)
JP (1) JP2012505665A (https=)
CN (1) CN102186968A (https=)
AU (1) AU2009305532A1 (https=)
CA (1) CA2740578A1 (https=)
WO (1) WO2010045645A1 (https=)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106337036A (zh) * 2016-08-26 2017-01-18 杭州易文赛生物技术有限公司 一种提高脂肪组织中cd34阳性血管基质成分提取率的方法
CN106399234A (zh) * 2016-08-31 2017-02-15 肖锷 脂肪组织的处理方法及间充质干细胞、处理后单个脂肪细胞和细胞外基质
CN106796215A (zh) * 2014-08-05 2017-05-31 Screencell公司 检测镰状细胞病的方法以及实施该方法的试剂盒
CN108261424A (zh) * 2018-01-24 2018-07-10 中国医学科学院医药生物技术研究所 一种新型的肝癌生物治疗方法
CN111518761A (zh) * 2020-05-25 2020-08-11 青岛瑞思德生物科技有限公司 一种间充质干细胞体外筛选、激活、扩增、冻存及其细胞库建立的方法

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9234897B2 (en) * 2005-03-31 2016-01-12 Two Cells Co., Ltd Method for distinguishing mesenchymal stem cell using molecular marker and use thereof
JP2015508101A (ja) 2012-02-21 2015-03-16 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ Ｃｄ３４＋細胞を含む薬学的組成物
WO2014089554A1 (en) * 2012-12-07 2014-06-12 Antria, Inc. Formulations containing and kit for using adipose-derived stem cells and use thereof
JP2016017068A (ja) * 2014-07-10 2016-02-01 国立大学法人金沢大学 脂肪組織由来間質細胞群を含む消化管炎症治療剤
EP3360957A4 (en) * 2015-10-08 2019-03-13 Kaohsiung Medical University COMPOSITION FOR THE QUICK SEPARATION OF CELLS FROM FAT
WO2017141831A1 (ja) * 2016-02-16 2017-08-24 ロート製薬株式会社 脂肪組織由来間質細胞を含む虚血性疾患治療剤およびその製造方法
US12161688B2 (en) 2016-06-30 2024-12-10 Mapi Pharma Ltd Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells
AU2018270396B2 (en) 2017-05-15 2025-03-20 Stem Cell Medicine Ltd. Treatment of multiple sclerosis with adipose-derived stem cells
WO2018211486A1 (en) 2017-05-15 2018-11-22 Stem Cell Medicine Ltd. Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells
US20210369608A1 (en) * 2018-02-23 2021-12-02 Regeneration Biomedical, Inc. Methods, apparatuses and systems for instilling stem cells and pharmaceuticals into the human ventricular system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808532A (en) * 1985-07-01 1989-02-28 The United States Of America As Represented By The United States Department Of Energy Continuous human cell lines and method of making same
US5968753A (en) * 1994-06-14 1999-10-19 Nexell Therapeutics, Inc. Positive and positive/negative cell selection mediated by peptide release
BRPI0607045A2 (pt) * 2005-01-31 2009-08-04 Cognate Therapeutics Inc células estromais adultas derivadas de adiposas exibindo caracterìsticas de células endoteliais
EP1989290B1 (en) * 2006-03-07 2015-07-08 Humacyte Method for endothelial cell extraction from adipose tissues

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106796215A (zh) * 2014-08-05 2017-05-31 Screencell公司 检测镰状细胞病的方法以及实施该方法的试剂盒
CN106337036A (zh) * 2016-08-26 2017-01-18 杭州易文赛生物技术有限公司 一种提高脂肪组织中cd34阳性血管基质成分提取率的方法
CN106399234A (zh) * 2016-08-31 2017-02-15 肖锷 脂肪组织的处理方法及间充质干细胞、处理后单个脂肪细胞和细胞外基质
CN108261424A (zh) * 2018-01-24 2018-07-10 中国医学科学院医药生物技术研究所 一种新型的肝癌生物治疗方法
CN108261424B (zh) * 2018-01-24 2020-11-06 中国医学科学院医药生物技术研究所 一种肝癌的生物治疗方法
CN111518761A (zh) * 2020-05-25 2020-08-11 青岛瑞思德生物科技有限公司 一种间充质干细胞体外筛选、激活、扩增、冻存及其细胞库建立的方法
CN111518761B (zh) * 2020-05-25 2022-04-29 青岛瑞思德生物科技有限公司 一种间充质干细胞体外筛选、激活、扩增、冻存及其细胞库建立的方法

Also Published As

Publication number Publication date
EP2356214A1 (en) 2011-08-17
AU2009305532A1 (en) 2010-04-22
CA2740578A1 (en) 2010-04-22
WO2010045645A1 (en) 2010-04-22
JP2012505665A (ja) 2012-03-08
US20110274667A1 (en) 2011-11-10

Similar Documents

Publication Publication Date Title
CN102186968A (zh) 从脂肪组织获得细胞群的方法
JP6246754B2 (ja) 組織修復のための混合細胞集団および細胞処理のための単離技術
RU2433177C2 (ru) Способ экспансии клеток, способ получения кондиционной среды, популяция адгезивных мезенхимальных стромальных клеток плаценты или жировой ткани, фармацевтическая композиция и применение адгезивных мезенхимальных стромальных клеток плаценты или жировой ткани в трансплантации
JP6947430B2 (ja) 細胞培養方法
JP6571537B2 (ja) 療法および予防のための細胞を単離する方法
JP2010508818A5 (https=)
CN101263224A (zh) 脂肪组织衍生的基质干细胞在治疗瘘中的用途
WO2012091911A1 (en) Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof
JP6931656B2 (ja) クローン病における肛囲複雑瘻孔の治療において使用するための脂肪組織由来間質幹細胞
WO2015004609A2 (en) Adherent cells from placenta and use thereof in treatment of injured tendons
US10293003B2 (en) Multilineage-differentiating stress enduring (MUSE) cells for treatment of chronic kidney disease
US11578306B2 (en) Methods for propagating mesenchymal stem cells (MSC) for use in transplantation
KR102506612B1 (ko) 내피 기능장애 및 염증 질환의 치료
ES2833076T3 (es) Métodos para el tratamiento de la obesidad y/o el síndrome metabólico
US9956250B2 (en) Use of allogeneic interstitial vessel-layer cell and allogeneic mesenchymal progenitor cell for preventing or treating osteoarthritis
HK1161303A (en) Methods of obtaining cell populations from adipose tissue
El-Hashash general discussion, remarks
HK1238561B (zh) 治疗移植物抗宿主疾病的方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1161303

Country of ref document: HK

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20110914

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1161303

Country of ref document: HK